Accessibility Menu
 
Pharvaris logo

Pharvaris

(NASDAQ) PHVS

Current Price$30.38
Market Cap$1.99B
Since IPO (2021)+5%
5 Year+42%
1 Year+91%
1 Month+4%

Pharvaris Financials at a Glance

Market Cap

$1.99B

Revenue (TTM)

$0.00

Net Income (TTM)

$169.20M

EPS (TTM)

$-3.18

P/E Ratio

-9.57

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$30.38

Volume

21,501

Open

$30.65

Previous Close

$30.38

Daily Range

$29.35 - $30.65

52-Week Range

$15.46 - $33.33

PHVS: Motley Fool Moneyball Superscore

57

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharvaris

Industry

Pharmaceuticals

Employees

129

CEO

Berndt A. E. Modig, MBA, CPA

Headquarters

Leiden, 2333 CH, NL

PHVS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-76%

Return on Capital

-73%

Return on Assets

-65%

Earnings Yield

-10.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.99B

Shares Outstanding

65.41M

Volume

21.50K

Avg. Volume

247.71K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$169.82M

EBITDA

$169.40M

Operating Cash Flow

$137.07M

Capital Expenditure

$164.62K

Free Cash Flow

$137.24M

Cash & ST Invst.

$291.68M

Total Debt

$776.80K

Pharvaris Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$106.45K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.99B

N/A

Market Cap/Employee

$18.41M

N/A

Employees

108

N/A

Net Income

$39.85M

+14.0%

EBITDA

$44.89M

-6.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$246.48M

+4.5%

Accounts Receivable

$4.98M

+88.4%

Inventory

$0.00

N/A

Long Term Debt

$533.13K

-2.4%

Short Term Debt

$206.53K

+6.1%

Return on Assets

-65.06%

N/A

Return on Invested Capital

-72.81%

N/A

Free Cash Flow

$49.62M

-28.4%

Operating Cash Flow

$49.57M

-28.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMNMImmunome, Inc.
$20.88-5.18%
BCRXBioCryst Pharmaceuticals, Inc.
$9.02-5.75%
ZYMEZymeworks Inc.
$23.93-0.13%
ARDXArdelyx, Inc.
$6.23-3.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.62-0.05%
NOKNokia
$13.95-0.04%
FFord Motor Company
$13.40-0.07%
POETPoet Technologies
$15.97-0.22%

Questions About PHVS

What is the current price of Pharvaris?

Pharvaris is trading at $30.38 per share.

What is the 52-week range for Pharvaris?

Over the past 52 weeks, Pharvaris has traded between $15.46 and $33.33.

How much debt does Pharvaris have?

As of the most recent reporting period, Pharvaris reported total debt of $851,350.21.

How much cash does Pharvaris have on hand?

Pharvaris reported $284.55M in cash and cash equivalents in its most recent financial results.

What is Pharvaris’s dividend yield?

Pharvaris does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.